OCGNOcugen, Inc.
What is the market doing?
In a downtrend (−34% vs 200-day). That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.
In a downtrend, below its 50- and 200-day averages. Price is −34% vs its 200-day average.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How OCGN is trading
Ocugen, Inc. is −44% over the past year while the S&P 500 is +18%: 62 points behind the market. Through the fall, its own insiders bought $26K more stock than they sold.
1-year return · S&P 500 +18%
- vs 200-day average
- −34%
vs 200-day average · a clear downtrend
- RSI (14)
- 40
RSI (14) · neutral
- Below its 52-week high
- 60%
Below its 52-week high
Details›
- Last close2026-10-08
- $0.98
- 1 monthS&P 500 +1.6%
- −9.0%
- 1 yearS&P 500 +18%
- −44%
- 5 yearsS&P 500 +86%
- −86%
- vs 50-day average$1.20
- −18%
- 52-week high
- $2.48
- 52-week low
- $0.98
- Annualised volatility
- 78%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-10-08
- $26K
| Year | Return |
|---|---|
| 2026 (year to date) | −27% |
| 2025 | +68% |
| 2024 | +40% |
| 2023 | −56% |
| 2022 | −71% |
| 2021 | +149% |
| 2020 | +252% |
| 2019 | −90% |
| 2018 | −96% |
| 2017 | +23% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 4 of 10 | +13% |
| Feb | 10 | 4 of 10 | +53% |
| Mar | 10 | 4 of 10 | −0.95% |
| Apr | 10 | 5 of 10 | +9.0% |
| May | 10 | 4 of 10 | −5.5% |
| Jun | 10 | 5 of 10 | +1.2% |
| Jul | 11 | 6 of 11 | +11% |
| Aug | 11 | 5 of 11 | +6.8% |
| Sep | 11 | 3 of 11 | −17% |
| Oct | 11 | 3 of 11 | +0.05% |
| Nov | 10 | 3 of 10 | −20% |
| Dec | 10 | 5 of 10 | +42% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.